PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportsglaucoma
MeSH D005901 - glaucoma
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D009798:Ocular hypertension
18 Companies
11 Drugs
$
Success rate
D005901: 
Glaucoma
58 Companies
6 Drugs
$
Success rate
D005902:Open-angle glaucoma
101 Companies
38 Drugs
$
Success rate
D015355:Neovascular glaucoma
0 Companies
0 Drugs
Success rate
D015812:Angle-closure glaucoma
22 Companies
4 Drugs
$
Success rate
D057066:Low tension glaucoma
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaAcetazolamide Diamox  1982-01-01   
Novast LaboratoriesAcetazolamide Acetazolamide  2016-09-30   
Taro PharmaceuticalAcetazolamide Acetazolamide  1997-05-28   
MylanAcetazolamide Acetazolamide  2012-05-09   
Chartwell PharmaceuticalsAcetazolamide Acetazolamide  1982-01-01   
Aurobindo PharmaAcetazolamide Acetazolamide  2025-05-30   
1
2
3
4
5
6
>
Clinical Trials
Historical Success Rate
Phase 1
50%
11/22
Phase 2
82%
14/17
Phase 3
63%
25/40
Approved: 5Overall Success rate: 26%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Mylan
Aspartame
Boehringer Ingelheim
Chlorthalidone,
Clonidine
Novartis
Bevifimod,
Telbermin,
Globulin, immune,
RKI983,
Sad448
Merck & Co
Maxacalcitol,
Ins117548,
Histone-arginine methyltransferase carm1,
Surlorian
1
2
3
4
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use